Key result
Propranolol at doses of 80, 160, or twice daily provided no greater hypotensive response than twice daily in patients with essential hypertension.
Why the study?
Does higher dose propranolol (80, 160, or 240 mg twice daily) improve hypotensive response compared to 40 mg twice daily in patients with essential hypertension?
RCT (n=24)
Double-blind
Does higher dose propranolol (80, 160, or 240 mg twice daily) improve hypotensive response compared to 40 mg twice daily in patients with essential hypertension?
Increasing the dose of propranolol above 40 mg twice daily does not provide additional blood pressure lowering in patients with essential hypertension.
Answers are grounded in this paper and cite their sources.
Supports limiting propranolol to 40 mg twice daily in essential hypertension; confirms no added benefit from higher doses in this RCT.
In a double-blind crossover study, it has been shown that the hypotensive response to propranolol in 24 patients with essential hypertension was no greater at doses of 80, 160, or 240 mg twice daily than at 40 mg twice daily. A relationship was observed between dose and response as defined by the ability to achieve a standing diastolic blood pressure of 95 mm Hg. Four patients with low plasma renin activity (PRA) had no fall in blood pressure even at highest dose levels. Plasma propranolol levels in the groups were related to dose, and up to a concentration of 300 ng/ml, with degree of beta-adrenoceptor blockade; there was, however, no correlation with hypotensive response.
No takes yet. Share an insight, caveat, or question.
Serlin et al. (1980) conducted an RCT in essential hypertension (n=24). Propranolol vs. 40 mg twice daily was evaluated on hypotensive response. Propranolol at doses of 80, 160, or twice daily provided no greater hypotensive response than twice daily in patients with essential hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: